DOJ Probes Cephalon Over Narcolepsy Drug Marketing

Law360, New York (September 30, 2011, 2:13 PM EDT) -- Cephalon Inc. said Friday that the U.S. Department of Justice had asked it to turn over documents detailing its promotion of narcolepsy drugs Nuvigil and Provigil, just days after Cephalon admitted federal prosecutors were also probing its leukemia drug Treanda.

The Frazier, Pa.-based drugmaker — which Teva Pharmaceutical Industries Ltd. plans to buy for $6.8 billion — has also received another DOJ subpoena as part of an investigation into the off-label use of Treanda for non-Hodgkin's lymphoma, according to pharmaceutical blog Pharmalot.

In a U.S. Securities...
To view the full article, register now.